SNP polymorphisms that have been known to affect the pharmacokinetic parameters of fluoroquinolone as an important drug in the treatment of MDR-TB are found in the UGT1A1, UGT1A9, SLCO1B1, and ABCB1 genes. The gene discussed is UGT1A1; the disease is multidrug-resistant tuberculosis.